ICYMI: Senator Hassan's Bipartisan Opioid Addiction Risk Transparency Act Signed Into Law as Part of FDA Bill
August 22, 2017
August 22, 2017
WASHINGTON, Aug. 22 -- The office of Sen. Maggie Hassan, D-N.H., issued the following news release:
Last week, President Trump signed the Food and Drug Administration Reauthorization Act of 2017 into law, which included two measures championed by Senator Maggie Hassan.
The FDA Reauthorization bill included the bipartisan Opioid Addiction Risk Transparency Act, which Senator Hassan authored with Senator Todd Young (R-IN), and takes important steps to help ensure that doc . . .
Last week, President Trump signed the Food and Drug Administration Reauthorization Act of 2017 into law, which included two measures championed by Senator Maggie Hassan.
The FDA Reauthorization bill included the bipartisan Opioid Addiction Risk Transparency Act, which Senator Hassan authored with Senator Todd Young (R-IN), and takes important steps to help ensure that doc . . .